No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AGRX Agile Therapeutics
- 0.399
- -0.001-0.32%
15min DelayTrading Apr 25 11:27 ET
2.74MMarket Cap-59P/E (TTM)
0.420High0.373Low54.52KVolume0.373Open0.400Pre Close21.98KTurnover0.80%Turnover RatioLossP/E (Static)6.86MShares6.71452wk High-0.17P/B2.74MFloat Cap0.20052wk Low--Dividend TTM6.85MShs Float26380.000Historical High--Div YieldTTM11.67%Amplitude0.200Historical Low0.403Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Agile Therapeutics Releases Updated Investor Presentation
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript
Agile Therapeutics' Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout
Q4 2023 Agile Therapeutics Inc Earnings Call
Earnings Call Summary | Agile Therapeutics(AGRX.US) Q4 2023 Earnings Conference
The following is a summary of the Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript:Financial Performance:Agile Therapeutics reported a full year net revenue of $19.6 million in 2023, a
Agile Therapeutics Q4 Adj $(1.46) Misses $(0.92) Estimate, Sales $3.62M Miss $4.07M Estimate
Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(0.92) by 58.7 percent. This is a 83.78 percent increase over losses of
Comments
$Agile Therapeutics(AGRX.US$ few at $0.176. let's see
Therapeutics Company Successfully Repays Debt Facility: Debt-Free Focused
Agile Therapeutics Steers Towards Prosperity: Debt-Free and Focused on the Future.
In a significant financial milestone, Agile Therapeutics, Inc. (Nasdaq: AGRX), a renowned name in women's healthcare, has successfully repaid its debt facility with Perceptive Advisors. This accomplishment has placed the company in a strong financial position, clearing the way for it to focus on executing its business plan. $Agile Therapeutics(AGRX.US$
...
In a significant financial milestone, Agile Therapeutics, Inc. (Nasdaq: AGRX), a renowned name in women's healthcare, has successfully repaid its debt facility with Perceptive Advisors. This accomplishment has placed the company in a strong financial position, clearing the way for it to focus on executing its business plan. $Agile Therapeutics(AGRX.US$
...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg